Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04158466 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens
A NA study of Contact Lens Wear, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 16
- Study locations
NCT04158466 is a NA study of Contact Lens Wear that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 252 participants, below the 333-participant average among 3 other Contact Lens Wear trials with a reported enrollment target (24% lower). The trial reports 16 study locations across 10 states.
The verdict
NCT04158466, a NA study of Contact Lens Wear, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 16
- Study locations
Study Summary
This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
Conditions Studied
Interventions
- DEVICE Kalifilcon A Daily Disposable Contact Lenses
- DEVICE Biotrue ONEday Daily Disposable Contact Lenses
Study Locations (16)
California
- Bausch Site 8 - Los Angeles
- Bausch Site 9 - San Francisco
- Bausch Site 10 - Torrance
- Bausch Site 12 - Torrance
Tennessee
- Bausch Site 14 - Brentwood
- Bausch Site 5 - Memphis
- Bausch Site 3 - Nashville
Hawaii
- Bausch Site 16 - Honolulu
- Bausch Site 4 - ‘Aiea
Florida
- Bausch Site 6 - Sarasota
Kansas
- Bausch Site 7 - Pittsburg
Minnesota
- Bausch Site 11 - Bloomington
Missouri
- Bausch Site 1 - St Louis
New York
- Bausch Site 13 - Vestal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2019-05-31 |
| Est. Completion | 2019-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04158466
The ClinicalTrials.gov registry entry for NCT04158466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 333-participant average among 3 other Contact Lens Wear trials with a reported enrollment target (24% lower). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contact Lens Wear appearing as the primary indexed condition, and to 2 interventions - of which Kalifilcon A Daily Disposable Contact Lenses is the first listed.
NCT04158466 reports 16 study locations spanning 10 distinct geographic areas - top geographies include California, Tennessee, Hawaii.
Frequently Asked Questions
What is clinical trial NCT04158466 about?
NCT04158466 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens". This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.
What is the current status of trial NCT04158466?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2019-05-31. Estimated completion is 2019-11-12.
What conditions does trial NCT04158466 study?
This clinical trial studies the following conditions: Contact Lens Wear.
What interventions are being tested in trial NCT04158466?
The interventions under investigation include: Kalifilcon A Daily Disposable Contact Lenses (DEVICE), Biotrue ONEday Daily Disposable Contact Lenses (DEVICE).
Who is sponsoring clinical trial NCT04158466?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04158466 being conducted?
This trial has 16 study locations across California, Florida, Hawaii, Kansas, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contact Lens Wear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.